Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen L Goode

Showing results (31-40 of 323) with videos related to

Pageof 33
Sort By:
Frontiers in Medicine|September 26, 2022
Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinomaJun Jiang, Burak Tekin, Lin Yuan, et al.
BMC Medical Genomics|June 23, 2021
Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencingJaime I Davila, Pritha Chanana, Vivekananda Sarangi, et al.
BMC Proceedings|December 19, 2009
Single versus multiple imputation for genotypic dataBrooke L Fridley, Shannon K McDonnell, Kari G Rabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2011
Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancerJames Krempski, Lavakumar Karyampudi, Marshall D Behrens, et al.
BMC Proceedings|May 10, 2008
Analysis of variation in NF-kappaB genes and expression levels of NF-kappaB-regulated moleculesWen Liu-Mares, Zhifu Sun, William R Bamlet, et al.
Oncology|January 19, 2016
Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian CancerAminah Jatoi, Robert A Vierkant, Kieran M Hawthorne, et al.
Plos One|November 19, 2013
The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancerClaudia C Preston, Matthew J Maurer, Ann L Oberg, et al.
G3 (Bethesda, Md.)|October 13, 2016
Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three SubtypesGregory P Way, James Rudd, Chen Wang, et al.
Genetic Epidemiology|May 24, 2014
Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancerStacey J Winham, Sebastian M Armasu, Mine S Cicek, et al.
Journal of Human Genetics|January 12, 2018
Mediation analysis of alcohol consumption, DNA methylation, and epithelial ovarian cancerDongyan Wu, Haitao Yang, Stacey J Winham, et al.
Pageof 33

Showing results (31-40 of 323) with videos related to

Sort By:
Pageof 33
Frontiers in Medicine|September 26, 2022
Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinomaJun Jiang, Burak Tekin, Lin Yuan, et al.
BMC Medical Genomics|June 23, 2021
Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencingJaime I Davila, Pritha Chanana, Vivekananda Sarangi, et al.
BMC Proceedings|December 19, 2009
Single versus multiple imputation for genotypic dataBrooke L Fridley, Shannon K McDonnell, Kari G Rabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2011
Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancerJames Krempski, Lavakumar Karyampudi, Marshall D Behrens, et al.
BMC Proceedings|May 10, 2008
Analysis of variation in NF-kappaB genes and expression levels of NF-kappaB-regulated moleculesWen Liu-Mares, Zhifu Sun, William R Bamlet, et al.
Oncology|January 19, 2016
Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian CancerAminah Jatoi, Robert A Vierkant, Kieran M Hawthorne, et al.
Plos One|November 19, 2013
The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancerClaudia C Preston, Matthew J Maurer, Ann L Oberg, et al.
G3 (Bethesda, Md.)|October 13, 2016
Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three SubtypesGregory P Way, James Rudd, Chen Wang, et al.
Genetic Epidemiology|May 24, 2014
Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancerStacey J Winham, Sebastian M Armasu, Mine S Cicek, et al.
Journal of Human Genetics|January 12, 2018
Mediation analysis of alcohol consumption, DNA methylation, and epithelial ovarian cancerDongyan Wu, Haitao Yang, Stacey J Winham, et al.
Pageof 33